Effects of GLYX-13 on Learning and Memory in Healthy Individuals and Those With Psychiatric Illness

Summary

The present study proposes to evaluate the potential cognitive enhancing effects of GLYX-13, an NMDAR partial agonist, among a group of healthy adults and those with psychiatric illness on a series of functional magnetic resonance imaging (fMRI) learning and memory tasks.

Timeline

Start

2013-05

Primary completion

2016-01

Completion

2016-01

Drugs

Indications